Compare UHS & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UHS | HLI |
|---|---|---|
| Founded | 1978 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 10.6B |
| IPO Year | 1994 | 2015 |
| Metric | UHS | HLI |
|---|---|---|
| Price | $180.03 | $153.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $233.00 | $194.29 |
| AVG Volume (30 Days) | 584.6K | ★ 585.5K |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | 0.44% | ★ 1.58% |
| EPS Growth | 37.34 | ★ 41.61 |
| EPS | ★ 23.10 | 4.74 |
| Revenue | ★ $17,364,829,000.00 | $2,389,416,000.00 |
| Revenue This Year | $7.70 | $14.31 |
| Revenue Next Year | $4.96 | $12.52 |
| P/E Ratio | ★ $7.83 | $32.04 |
| Revenue Growth | 9.71 | ★ 24.81 |
| 52 Week Low | $152.33 | $134.41 |
| 52 Week High | $246.33 | $211.78 |
| Indicator | UHS | HLI |
|---|---|---|
| Relative Strength Index (RSI) | 37.93 | 60.96 |
| Support Level | $173.79 | $135.21 |
| Resistance Level | $186.19 | $197.08 |
| Average True Range (ATR) | 4.95 | 4.20 |
| MACD | 0.98 | 2.45 |
| Stochastic Oscillator | 39.15 | 96.18 |
Universal Health Services primarily offers healthcare services through its behavioral health centers, acute care hospitals, and related outpatient facilities. As of late 2025, the company operated 346 inpatient behavioral health centers, 29 acute care hospitals, and many supportive outpatient facilities. Its operations are concentrated in the US, particularly in Nevada (21% of 2025 operating profits), Texas (19%), and California (13%), although it does have some exposure to the UK behavioral health market (6% of 2025 sales) too. While its acute care services account for over 55% of revenue, the behavioral health centers sport higher margins and account for over 55% of pretax profits.
Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.